2016
DOI: 10.1158/0008-5472.can-15-3121
|View full text |Cite
|
Sign up to set email alerts
|

Upregulated Glucose Metabolism Correlates Inversely with CD8+ T-cell Infiltration and Survival in Squamous Cell Carcinoma

Abstract: Antibodies that block T-cell-regulatory checkpoints have recently emerged as a transformative approach to cancer treatment. However, the clinical efficacy of checkpoint blockade depends upon inherent tumor immunogenicity, with variation in infiltrating T cells contributing to differences in objective response rates. Here, we sought to understand the molecular correlates of tumor-infiltrating T lymphocytes (TIL) in squamous cell carcinoma (SCC), using a systems biologic approach to integrate publicly available … Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
68
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 88 publications
(75 citation statements)
references
References 48 publications
7
68
0
Order By: Relevance
“…This effect is mediated by the absence of the glycolytic product phosphoenolpyruvate, which sustains Ca 2+ and NFAT by blocking sarco/endoplasmic reticulum Ca 2+ -ATPase (Ho et al, 2015). In line with this, our group observed a negative correlation between accelerated tumoral glucose metabolism and T-cell infiltration in renal cell carcinoma (Singer et al, 2011), with similar observations made in oral squamous cell carcinoma (Ottensmeier et al, 2016). Interestingly, emerging clinical data point towards tumor glucose metabolism as a mechanism of resistance to T-cell-mediated tumor rejection.…”
Section: Tumors Modulate Local Concentrations Of Nutrients That Are Csupporting
confidence: 85%
“…This effect is mediated by the absence of the glycolytic product phosphoenolpyruvate, which sustains Ca 2+ and NFAT by blocking sarco/endoplasmic reticulum Ca 2+ -ATPase (Ho et al, 2015). In line with this, our group observed a negative correlation between accelerated tumoral glucose metabolism and T-cell infiltration in renal cell carcinoma (Singer et al, 2011), with similar observations made in oral squamous cell carcinoma (Ottensmeier et al, 2016). Interestingly, emerging clinical data point towards tumor glucose metabolism as a mechanism of resistance to T-cell-mediated tumor rejection.…”
Section: Tumors Modulate Local Concentrations Of Nutrients That Are Csupporting
confidence: 85%
“…As tumor cells can express more nutrient import molecules than activated T cells, tumor cells commonly outcompete immune cells for glucose. Indeed, overexpression of GLUT1 in cancer cells correlates with low CD8 T cell infiltration in renal cell carcinoma (Singer et al, 2011) and SCC (Ottensmeier et al, 2016), and poor patient prognosis in melanoma (Su et al, 2016), PDA (Davis-Yadley et al, 2016; Lu et al, 2016) and ovarian cancer (Cho et al, 2013). Successful competition for glucose by tumor cells facilitates the capacities to simultaneously maintain high metabolic and proliferative rates while suppressing anti-tumor immunity.…”
Section: Metabolic Challenges In the Tme: Impact On T Lymphocytes Andmentioning
confidence: 99%
“…High lactate levels inhibited proliferation and cytokine production in human cytotoxic lymphocytes, which was attributed to disruption of a required lactate gradient, prevention of lactate export, and metabolic perturbation[94]. Additionally, in squamous tumors, highly glycolytic tumors had reduced CD8+ T cell infiltration[95]. …”
Section: Tumor Infiltrating Lymphocytes and Metabolic Adaptationmentioning
confidence: 99%